StonvexLoading…
StonvexStonvexStonvexCore line items from PNTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $947.71M | $695.24M | $544.89M | $473.24M |
Operating Income | $51.89M | $38.12M | $25.17M | $12.74M |
Net Income | $29.58M | $22.56M | $13.38M | $6.64M |
EPS (Diluted) | $0.84 | $0.70 | $0.44 | $0.22 |
Total Assets | $968.18M | $679.52M | $539.69M | $512.12M |
Total Liabilities | $593.93M | $367.56M | $394.18M | $386.46M |
Cash & Equivalents | $17.02M | $24.25M | $6.06M | $2.08M |
Free Cash Flow OCF − CapEx | $36.26M | $30.31M | $24.98M | $-5.13M |
Shares Outstanding | 34.63M | 34.37M | 29.95M | 29.69M |